The analytical sensitivity of Idylla in detecting KRAS mutations has been reported to be in the range of 0.1–1% and a recent comparison between Idylla and NGS for plasma KRAS mutations in NSCLC showed a very high overall agreement [10]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.